Pictet-Biotech I dy GBP (FUND:B554RF5) - Fund price


Fund Report

Pictet-Biotech I dy GBP

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Size
Share Class Size (mil)8.05 GBP
(19/08/2019)
Fund Size (mil)1,208.66 USD
(19/08/2019)
Mkt Cap % 31/07/2019
FundCat
Giant5.835.20
Large35.9628.41
Medium38.1338.03
Small19.3026.73
Micro0.771.63
Valuations and Growth Rates 31/07/2019
FundCategory
Price / Earnings14.1817.07
Price/Book4.314.67
Price/Sales5.855.53
Price/Cash Flow14.1112.19
Dividend-Yield Factor0.530.40
Long-Term Projected Earnings Growth13.3515.57
Historical Earnings Growth18.5724.52
Sales Growth12.1613.72
Cash-Flow Growth0.566.39
Book-Value Growth15.279.76

Asset Allocation % 31/07/2019

Asset Allocation
LongShortNetCat
Stocks96.200.0096.2099.57
Bonds0.000.000.000.03
Cash5.932.133.80-0.65
Other0.000.000.001.05
World Regions % 31/07/2019
FundCategory
Greater Europe8.268.33
United Kingdom1.241.70
Eurozone4.334.17
Europe - ex Euro2.682.28
Europe - Emerging0.000.00
Africa0.000.00
Middle East0.000.17
Americas90.2789.58
United States90.2789.40
Canada0.000.18
Latin America0.000.00
Greater Asia1.472.09
Japan0.000.68
Australasia0.000.04
Asia - Developed0.000.30
Asia - Emerging1.471.07
Stock Sector Weightings % 31/07/2019
FundCategory
Cyclical0.000.00
Basic Materials-0.00
Consumer Cyclical--
Financial Services--
Real Estate--
Sensitive0.003.87
Communication Services--
Energy--
Industrials-0.29
Technology-3.58
Defensive100.0096.13
Consumer Defensive-0.23
Healthcare100.0095.90
Utilities--

Top 10 Holdings31/07/2019

Assets in Top 10 Holdings %41.20
Total Number of Equity Holdings52
Total Number of Bond Holdings0
NameSectorCountry%
IncreaseDecreaseNew since last portfolio
IncreaseGilead Sciences Inc HealthcareUnited States8.04
IncreaseVertex Pharmaceuticals Inc HealthcareUnited States6.26
IncreaseAmgen Inc HealthcareUnited States4.55
IncreaseRegeneron Pharmaceuticals Inc HealthcareUnited States4.16
IncreaseBiogen Inc HealthcareUnited States4.11
DecreaseAlexion Pharmaceuticals Inc HealthcareUnited States3.96
IncreaseBiomarin Pharmaceutical Inc HealthcareUnited States3.62
IncreaseCelgene Corp HealthcareUnited States3.30
IncreaseSarepta Therapeutics Inc HealthcareUnited States3.21
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.